MentionFox
Home › funding signals › Janeen
Accelerator · announced

Janeen (YC W26) — Prior auths and benefits investigation for infusion clinics

Janeen is built for infusion clinics. We handle prior authorizations and benefit investigations from start to finish (actually though!).

Janeen is a Y Combinator company in the Winter 2026 batch. Its directory entry describes it as: Prior auths and benefits investigation for infusion clinics. The founder listed is Meng Fei Shen (Founder/CEO) (Y Combinator directory entry, January 28, 2026).

6 more companies from YC Winter 2026 ↓

Run the free check on Janeen →

Sell to companies like Janeen? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Janeen

New accelerator entry · 2026-01-28 · the record

Winter 2026
batch
5
people
Early
stage
United States of America
region
Open the record →

What the record says

BatchWinter 2026
Announced2026-01-28
StageEarly
StatusActive
Team size5
IndustryHealthcare
Sub-industryHealthcare
RegionsUnited States of America, America / Canada
BasedSan Francisco, CA, USA
HiringYes
Sitehttps://janeen.care
Previously known asRuma Care

Pitching, partnering or investing alongside them? See who really runs and owns Janeen.

Free to see. No signup.

Keep reading

More on Janeen and the records around it.

Also in YC Winter 2026

Same batch, Healthcare first.

What do you want to do with Janeen?

Get the full cited report on Janeen

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on Janeen: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

In their words

Janeen is built for infusion clinics. We handle prior authorizations and benefit investigations from start to finish (actually though!). Biologics are expensive medications that cost $80-$150K+ per year per patient, and often need to be administered in specific settings called infusion clinics. Medical providers buy these drugs up front to secure pricing deals and safer inventory - they are reimbursed for the cost of the medications through the patients’ insurance. Current medical workflows aren't built for infusion clinics. Inventory, storage, transport, and billing is still managed through paper and excel spreadsheets. And because they’re so expensive, these specialty medications are denied by insurers at a rate of 37% each year. When they are denied, when workflows fail, or patients are infused before paperwork is cleared, providers don’t get reimbursed for the medication and are left covering the costs. Ruma Care solves this so clinics get paid, patients get treated faster, and care teams spend less time fighting forms. We work with clinics across the country and have removed 95% of all manual labor in the process.

Want the whole picture on Janeen?

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on Janeen: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Janeen covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Is this you?

If you're behind Janeen: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. GetFoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.

Sourced from the company's Y Combinator directory entry.

RSS

Tools for this story

Each opens in a new tab, filled in for Janeen. With no account yet, you sign up free and land on the result.

Share this page

Is this your company?

Share the news. Sharing needs no account.

Janeen: Accepted into Y Combinator Winter 2026
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/yc-janeen
Last updated 2026-10-20
Primary record: Y Combinator directory entry
Janeen (YC W26) — Prior auths and benefits investigation for infusion clinics. MentionFox, 2026-10-20. https://mentionfox.com/funding/yc-janeen